ReviewMolecular plant pathology2021
Current status and future prospects of grapevine anthracnose caused by Elsinoe ampelina: An important disease in humid grape-growing regions.
Review in Molecular plant pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- The Potential of Microorganisms for the Control of Grape Downy Mildew-A Review.Journal of fungi (Basel, Switzerland) · 2024Review
- Metabolomics analysis based on UHPLC-QqQ-MS/MS to discriminate grapes and wines from different geographical origins and climatological characteristics.Food chemistry: X · 2024Article
- Insights into Grape Ripe Rot: A Focus on thePlants (Basel, Switzerland) · 2023Review
- Article
- A cool climate perspective on grapevine breeding: climate change and sustainability are driving forces for changing varieties in a traditional market.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2022Review
- A Field Collection of Indigenous Grapevines as a Valuable Repository for Applied Research.Plants (Basel, Switzerland) · 2022Article
- Current status and future prospects of grapevine anthracnose caused by Elsinoe ampelina: An important disease in humid grape-growing regions.Molecular plant pathology · 2021Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anthracnose, caused by Elsinoe ampelina, is one of the most destructive diseases of grapevines worldwide, especially in humid areas. E. ampelina mainly infects young tissues starting from shoots to berries and affects vine vigour and berry yield. The occurrence and the role of the sexual stage in the disease cycle and the grapevine-E. ampelina interaction remain poorly understood. However, the recent genome sequence data of E. ampelina provides the basis for further studies to understand its evolution, pathogenicity mechanisms, and effector repertoire. New studies on E. ampelina have been conducted in recent years. In this pathogen profile, we present a comprehensive literature review of E. ampelina to summarize the findings on its aetiology, infection mechanisms, genome, pathogenicity, and host resistance. TAXONOMY: Elsinoe ampelina Shear; Kingdom Fungi; Phylum Ascomycota; Subphylum Pezizomycotina; Class Dothideomycetes; Subclass Dothideomycetidae; Order Myriangiales Starbäck; Family Elsinoaceae Höhnel; Genus Elsinoe Racib. HOST RANGE: E. ampelina only infects Vitis species and hybrids. DISTRIBUTION: The grapevine anthracnose is distributed worldwide but is most prevalent in Argentina, Australia, Brazil, Canada, China, India, Japan, Korea, New Zealand, South Africa, Thailand, USA, and Uruguay. DISEASE SYMPTOMS: E. ampelina causes slightly abundant depressed spots on young leaves, petioles, stems, tendrils, rachises, and berries. Under severe infection conditions, early defoliation, berry dropping, and delayed berry development and ripening may occur. GENOME: The genomes of two E. ampelina isolates, YL-1 and CECT 20119, are publicly released with 8,057 and 10,207 predicted genes, respectively.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.